Year
2020
Status
Active
Team
Field
Autoimmune Diseases
Location
Oss (Netherlands)
Fund
BGV IV
Citryll
Citryll focuses on the development of a therapeutic antibody that inhibits neutrophil extracellular traps and their formation that are associated with a number of inflammatory diseases.